fr   en

Tableaux synoptiques (en anglais)

Parcourir par date
Rechercher par mot clé
Date: 2010-08-30
Acquiring pharma company: Lonza (Switzerland)
Acquired biotech company: Vivante GMP Solutions (USA)
Terms of the agreement: Lonza has purchased Vivante GMP Solutions, an American custom manufacturing organization dedicated to producing GMP viral-based therapeutics. This acquisition allows Lonza to broaden its biologics custom service offering for the viral vaccine and gene therapy markets.